'Too dangerous to release' is becoming AI's new normal
- Apr 27
- 1 min read
TIME — On April 16, OpenAI announced GPT-Rosalind, a new AI model targeted at the life sciences. It significantly outperforms their current publicly available models in chemistry and biology tasks, as well as experimental design.
As with Anthropic’s Claude Mythos and OpenAI’s GPT-5.4-Cyber, also released this month, the model is not available to the general public—reserved, at least initially, for “qualified customers” through a “trusted access program.”
Read the full story | TIME
